Sökresultat

The University is now a member of Scholars at Risk (SAR), an international network that helps vulnerable and persecuted academics. Professor Shirin Zubair visited Lund University and spoke about her situation as a persecuted academic. “This is in line with our core values as a university, which include defending and supporting academic freedom”, says Pär Svensson at External Relations, who is LU’s

https://www.staff.lu.se/article/lu-joins-network-help-scholars-risk - 2025-10-07

A large international study has identified three different pathways towards type 1 diabetes in children. Researchers at Lund University Diabetes Centre have contributed with data from a prospective study in southern Sweden. An important objective with the study published in Nature Communications is to gain a better understanding of how the disease develops to be able to take preventive measures. “

https://www.ludc.lu.se/article/large-international-study-points-three-pathways-towards-type-1-diabetes - 2025-10-07

Researchers at Lund University have discovered increased levels of a microRNA in type 2 diabetes, which has a negative effect on insulin secretion. Their experiments on human insulin producing cells in the pancreas also demonstrate that it is possible to increase the insulin secretion by reducing the levels of this microRNA. An important goal of the research is to develop new treatments for people

https://www.ludc.lu.se/article/newly-discovered-drug-candidate-increases-insulin-secretion-type-2-diabetes - 2025-10-07

Obesity and excess weight increase the risk of developing type 2 diabetes, but individuals of normal weight can also develop the disease. Researchers at Lund University have discovered that it is possible to identify at-risk individuals by measuring BMI in a new way. The authors of the study have identified metabolic alterations associated with obesity that can increase the risk of developing type

https://www.ludc.lu.se/article/new-way-measuring-bmi-can-predict-risk-type-2-diabetes-individuals-normal-weight - 2025-10-07

A new study by researchers at Lund University supports the notion that patients with type 2 diabetes should be divided into subgroups and given individualised treatment. The study demonstrates that there are distinct epigenetic differences between different groups of patients with type 2 diabetes. The epigenetic markers were also associated with different risks of developing common complications i

https://www.ludc.lu.se/article/epigenetic-markers-predict-complications-patients-type-2-diabetes - 2025-10-07

Epigenetics has become an important tool for researchers endeavoring to understand the causes and development stages of type 2 diabetes. In the future, epigenetic biomarkers could be used to predict type 2 diabetes and individualise its treatment. Diabetes and epigenetics researchers at Lund University summarise some of the most important advancements in a review article published in Nature Review

https://www.ludc.lu.se/article/epigenetics-can-pave-way-individualised-treatment-type-2-diabetes - 2025-10-07

Insulin secretion into the bloodstream requires a protein called CD59. New research led by Lund University shows that the two protein variants that are responsible for this function of CD59 are affected in diabetes. The study has been recently published in PNAS. Insulin affects many bodily functions, and is required for survival. It causes cells to take up glucose from the blood, storage of energy

https://www.ludc.lu.se/article/newly-discovered-protein-variants-are-key-insulin-secretion - 2025-10-07

Why do some people develop type 1 diabetes and others do not? Worldwide, researchers are now collaborating to find the answer to this complex question. Diabetes researchers at Lund University recently contributed data to a new study that shows that type 1 diabetes develops in three different ways in children. This improved understanding makes it possible for scientists to conduct new types of stud

https://www.ludc.lu.se/article/blood-testing-children-leads-better-understanding-type-1-diabetes - 2025-10-07

Three researchers at Lund University Diabetes Centre (LUDC) have each been awarded a project grant of 47,500 euro by the Hjelt Diabetes Foundation. The aim of all three projects is to improve our understanding of diabetes and ultimately enable better treatments of type 2 diabetes and its complications. One of the three projects uses advanced technology to learn more about the mechanisms behind dia

https://www.ludc.lu.se/article/new-funding-hjelt-diabetes-foundation-improve-understanding-diabetes - 2025-10-07

Impaired insulin secretion is closely associated with type 2 diabetes, but the process is not yet fully understood. A new study by researchers at Lund University shows that the Piezo1 ion channel regulates insulin secretion, which means it may be an important target for new diabetes treatments. Type 2 diabetes often occurs because the pancreatic beta cells are unable to produce enough effective in

https://www.ludc.lu.se/article/study-shows-piezo1-ion-channel-plays-important-role-insulin-secretion - 2025-10-07

We were interested to know what our Scientific Advisory Board think about the research currently underway at Lund University Diabetes Centre (LUDC), and invited Flemming Pociot and Søren Brunak from the board to the LUDC retreat in Helsingborg recently. They spent their time at the retreat listening to presentations and getting updates, and were able to provide valuable feedback. A presentation ab

https://www.ludc.lu.se/article/scientific-advisory-board-we-hope-see-more-data-about-subgroups - 2025-10-07

A large-scale faeces and blood sample study indicates strong associations between gut bacteria and metabolites in the blood. Among other findings, the research team behind the study has identified new associations between a common type 2 diabetes drug and the gut microbiome. The study was led by researchers at Uppsala University and Lund University. The role of the gut microbiome in disease and he

https://www.ludc.lu.se/article/gut-microbiome-research-indicates-new-bacteria-and-metformin-associations - 2025-10-07

Since Helena Elding Larsson began her career as a diabetes researcher and paediatrician, she has seen many improvements in the care of patients with diabetes. Her own research focuses on the prevention of the development of type 1 diabetes. Helena Elding Larsson is this year’s recipient of the Medeon stipend, and she will be speaking at the World Diabetes Day Skåne event, in Malmö on November 12th

https://www.ludc.lu.se/article/diabetes-researcher-helena-elding-larsson-wants-prevent-type-1-diabetes-developing - 2025-10-07

Six researchers at Lund University Diabetes Centre (LUDC) were recently awarded grants within medicine and health by the Swedish Research Council (Vetenskapsrådet). The six researchers are members of the strategic research area Excellence of diabetes research in Sweden (EXODIAB) at Lund University. Daniel Agardh, adjunct professor in pediatrics and research group leader in celiac disease and diabe

https://www.ludc.lu.se/article/several-diabetes-researchers-ludc-receive-grants-swedish-research-council - 2025-10-07

How much water do we need to drink to stay healthy? How do different diets affect our metabolism? Studies of various hormones in the body are providing diabetes researchers with new answers to these questions. The goal is to develop individualized treatments and dietary recommendations that could lower the risk of developing obesity and diseases such as type 2 diabetes. The endocrine system and th

https://www.ludc.lu.se/article/learning-more-about-endocrine-system-could-lead-fewer-cases-type-2-diabetes-and-obesity - 2025-10-07

World Diabetes Day in Malmö was all about science. Researchers told the latest on diabetes research from stem cells to diet and the smallest hade the opportunity to becoming scientists - and learn what makes a strawberry a strawberry .  Organisers:Lund University Diabetes Centre, Scania Hospital, Diabetes Society in Malmö/Lund and TEDDY.

https://www.ludc.lu.se/article/world-diabetes-day-malmo-2015 - 2025-10-07

Professor Charlotte Ling at Lund University Diabetes Centre (LUDC) has been awarded a Proof of Concept Grant by the European Research Council, ERC, for the further development of her successful research on epigenetic biomarkers. The innovation-driven research project will investigate biomarkers for predicting who benefits from metformin in the treatment of type 2 diabetes. In her research, Charlot

https://www.ludc.lu.se/article/erc-grant-research-diabetes - 2025-10-07

Tove Fall became a familiar face during the Covid-19 pandemic when she was often seen in Swedish media talking about the spread and progression of the disease in Sweden. She is also an outstanding diabetes researcher who uses large quantities of data to gain a better understanding of the development of diabetes. Tove Fall is now awarded the Leif C. Groop award for outstanding diabetes research for

https://www.ludc.lu.se/article/diabetes-researcher-tove-fall-recipient-leif-c-groop-award-2023 - 2025-10-07

Researchers have identified 395 genes that are differently expressed in people with type 2 diabetes. One of the genes proved to be very strongly associated with impaired insulin secretion. Now, researchers want to investigate if it is possible to use the genetic CRISPR/Cas9 scissors to correct the gene’s activity. The research team’s scientific paper was published in the Journal of Clinical Invest

https://www.ludc.lu.se/article/pax5-gene-strongly-associated-impaired-insulin-secretion-type-2-diabetes - 2025-10-07

A team of researchers led by Daniel E. Coral and Paul W. Franks at LUDC have used human genetics to do a phenome-wide analysis of the degree of genetic dissimilarity between obesity and type 2 diabetes. Together with colleagues from Dundee and Oxford universities in the UK and the Vanderbilt Genetics Institute in the US, the team recently published their findings in the journal Nature Metabolism.

https://www.ludc.lu.se/article/genetic-driven-approach-defining-two-obesity-profiles-convey-highly-concordant-and-discordant - 2025-10-07